Philips introduced a new eHealth lung screening solution on December 1st that will provide healthcare providers with a faster and more definitive pathway for lung cancer detection and treatment.
Unveiled at the 2014 Radiological Society of North America (RSNA) Annual Meeting in Chicago, the new solution is comprised of products and services that enable healthcare providers to implement and manage a comprehensive computed tomography (CT) lung screening programme which tracks and guides patients across the health continuum.
According to the Cancer Association of South Africa (CANSA), lung cancer is the leading cause of cancer deaths among South African men and it is the most common cancer worldwide. In South Africa, lung cancer is the second most common cancer in men and the sixth leading cancer in women in terms of diagnosis.
“Philips has long been at the forefront of offering sophisticated solutions for early detection of a wide range of conditions, but today’s clinicians need to integrate all relevant information quickly to reach a definitive diagnosis,” said Executive Vice President and CEO of Imaging Systems, Philips, Gene Saragnese.
“Philips is in a unique position to be able to offer not only the advanced imaging technology to make early lung cancer detection possible, but the data insights, collaboration and education tools that are needed to deliver the quality and consistency required for health systems to succeed in new, evidence-based models of patient care,” continued Saragnese.
In 2011, the National Lung Screening Trial (NLST) showed that diagnostic screening with low-dose CT reduced lung cancer deaths among a population of heavy smokers by 20 percent, when compared to using chest X-rays. It is also challenging to track and manage the patient population due to the high volume of measurements, data and changes in tumour and patient status over time.
According to Philips, their solution can be used with most low-dose CT scanners and consists of an integrated portfolio of products and services that together offers healthcare providers a complete programme for early lung cancer detection and ability to easily assess individual patient status as well as overall programme key performance indicators.
The Philips solution consists of several elements that, in combination, will allow healthcare providers to improve lung cancer screening and management with the ultimate goal of decreasing the overall mortality rate from the disease. The elements include services marketing to enable health systems to reach high-risk patients and their primary care physicians; Patient Management that will allow providers to follow a set of customised clinical protocols and establish interfaces with other hospital systems; Radiology Workflow to facilitate review and reporting of serial CT lung exams; and online Physician Education Resources.
The Philips lung screening and management system will be available in North America in the first half of 2015.